School of Medicine

Stanford Home
School of Medicine

Frontiers in Gene and Molecular Therapies
Lecture Series

Stanford University

Pediatrics

Genetics

Human Gene Therapy

PubMed

ASGT


2008-2009

Hosted by:

Mark A. Kay, M.D., Ph.D., Director of Human Gene Therapy

Sponsored by the Department of Pediatrics

3:00-4:00 p.m. at Munzer Auditorium
Beckman Center
Stanford University

Reception to follow

Scheduled Speakers:

 

November 13 , 2008: Dieter Gruenert, Ph.D., Senior Scientist, California Pacific Medical Center Research Institute, Adjunct Professor of the University of California, San Francisco and the University of Vermont

Sequence-specific gene modification: Implications for sickle cell anemia and cystic fibrosis



January 22, 2009: Punam Malik, M.D., Associate Professor of Pediatrics, Program Leader of the Molecular and Gene Therapy Program, and Deputy Director of the Comprehensive Sickle Cell Program for the University of Cincinnati

Gene therapy for red cell disorders



February 5, 2009: Ian MacLachlan, Ph.D., Chief Scientific Officer, Protiva Biotherapeutics, Inc.

Considerations for the development of siRNA-based drugs



April 2, 2009: Daniel Anderson, Ph.D., David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Combinatorial development of biomaterials for tissue engineering and drug delivery



April 23, 2009: David Root, Ph.D.
, Director of the RNA Interference Platform and Project Leader of the RNAi Consortium for the Broad Institute of the Massachusetts Institute of Technology

RNAi screening approaches to cancer



May 7, 2009: Kenneth S. Zaret, Ph.D., Chair in Cancer Biology, Leader of the Cell and Developmental Biology Program and Leader of the Keystone Program in Epigenetics and Progenitor Cells for the Fox Chase Cancer Center

Specifiying liver and pancreas progenitors


*May 14, 2009: Charles Coutelle, Ph.D., Professor, Imperial College, London

Towards Prevention of Genetic Disease by in utero Gene Therapy -- Animal models, target disease and ethical considerations

*Note special time of 2:00 p.m.-3:00 p.m.



May 21, 2009: Snorri Thorgeirsson, M.D., Ph.D., Chief, Laboratory of Experimental Carcinogenesis of the National Institutes of Health and the National Cancer Institute

"Genomics of human liver cancer"


 

Please check this site often for updates!

Lab Members

Ex-Lab Members

Contact Information

Research Interests

Publications

Fun Photos

Webmaster   Terms of Use   Last Updated: September 21, 2007